Monte Rosa Therapeutics, Inc. GLUE Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.32B.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s market capitalization?
- Monte Rosa Therapeutics, Inc. (GLUE) reported market capitalization of $1.32B in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s market capitalization changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s market capitalization increased by 361.2% year-over-year, from $285.41M to $1.32B.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Monte Rosa Therapeutics, Inc.'s market capitalization has grown at a 1.8% compound annual growth rate (CAGR), from $951.49M to $1.02B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.